A study published in the British Journal of Pharmacology on 3 March, led by University of Queensland researchers Associate Professor Trent Woodruff and Dr John Lee, has found the drug “PMX205” extends the life of mice that have a SOD1 mutation, when administered before or during very early disease onset. More studies are now underway to determine the safety of PMX205 before it can be tested in humans. 'Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis' tttp://onlinelibrary.wiley.com/doi/10.1111/bph.13730/full
Postive results for PMX205 in mice with SOD1 mutation
Latest News
Thank You to Old Bar Community Preschool
Old Bar Community Preschool recently held an MND Ice Bucket Challenge, raising $597 for MND NSW to support families experiencing MND - thank you for y...
Join the Team: Project Lead (Allied Health Professional - E-learning Development)
Be part of a dynamic, innovative and professional team working together for the best possible life for people living with Motor Neurone Disease. Proje...
Sandy’s MND Story
Adam and Kylie Downs have shared the MND story of their much-loved mother and mother-in-law, Sandra Currie. She loved to spend time with her family, w...
A pivotal step forward for the MND community in NSW as MND becomes a notifiable disease
MND NSW welcomes the NSW Government’s announcement that motor neurone disease (MND) will become a notifiable condition, marking a significant mileston...